top of page
Literature Review
Published date:
October 9, 2023
|

Public Health Data Analysis: Diabetes

Michelle Yang

1. Introduction

Diabetes, a chronic metabolic disease (World Health Organization: WHO, 2023), has emerged as a pressing concern in the field of public health. The National Diabetes Statistics Report has illustrated that 37.3 million Americans, approximately 1 in 10, have diabetes (The Facts, Stats, and Impacts of Diabetes, 2023). Diabetes can cause damage to both large (macrovascular) and small (microvascular) blood vessels, resulting in an increased risk of heart attack, stroke, and complications with the kidneys, eyes, gums, feet, and nerves. This has been demonstrated by the Department of Health and Human Services (2021).


Understanding the pathophysiology of diabetes is essential from a scientific standpoint to comprehend how individuals are affected by this condition. The pathophysiology of diabetes is characterized by elevated blood glucose levels, or hyperglycemia, which results from abnormalities in either insulin secretion, insulin action, or both.(Banday et al., 2019) More specifically, the exact cause of most types of diabetes is unknown. According to Mayo Clinic (2023), both types of diabetes can be caused by a combination of genetic and environmental factors.


It is equally important to acknowledge the significant influence of public health data analysis on both individuals and populations. This emphasizes the crucial need for comprehensive analysis to inform effective prevention, management, and policy strategies. In terms of its global impact, diabetes affects 422 million people, the majority of whom live in low- and middle-income countries. Additionally, diabetes is directly responsible for 1.5 million deaths worldwide annually. Over the past few decades, the frequency and number of diabetes cases have been continuously rising (World Health Organization: WHO, 2023).


The essential components of analyzing public health data for diabetes will be covered in more detail in the following sections. Our goal is to decrease the prevalence of diabetes and enhance the quality of life for individuals affected by this pervasive and chronic condition.


2. Current Trends

This study will examine various statistical data about the current trajectory of diabetes, encompassing global patterns, regional disparities, and demographic influences. On a global scale, approximately 422 million individuals are affected by diabetes, with a majority residing in low- and middle-income nations. Furthermore, diabetes is directly responsible for 1.5 million deaths annually. The prevalence of diabetes has exhibited a consistent rise over recent decades, a trend primarily attributed to sedentary lifestyles, inadequate dietary choices, and escalating rates of obesity (World Health Organization: WHO & World Health Organization: WHO, 2023).


The prevalence of diabetes displays notable variations across different regions. Notably, low- and middle-income countries in Asia, particularly India and China, have experienced a rapid surge in diabetes cases due to urbanization and shifts in dietary patterns, as illustrated in the figure below (Ke et al., 2022).


Figure 1: Burden of diabetes mellitus and its correlates in India and China.

According to a study conducted by the Centers for Disease Control and Prevention, various factors contribute to the increasing prevalence of diabetes. These factors encompass individuals with prediabetes, individuals who are overweight, individuals aged 45 years or older, individuals with a family history of type 2 diabetes, individuals who engage in physical activity less than three times per week, and individuals with a history of gestational diabetes or who have given birth to a baby weighing over 9 pounds (Diabetes Risk Factors, 2022). Conversely, certain regions have successfully stabilized or even reduced diabetes rates through the implementation of public health initiatives that promote healthy eating habits and regular physical activity.

Figure 2: Risk factors for diabetes (Catholic Health Initiatives, n.d.)

In summary, the escalating prevalence of diabetes worldwide is a cause for concern and necessitates immediate public health interventions. It is imperative to acknowledge that diabetes is a burgeoning global health issue, characterized by notable regional disparities. Identifying populations at heightened risk enables the implementation of prevention and treatment strategies with greater precision and efficacy.


3. Etiology

When examining the causes of diabetes, it becomes clear that multiple factors interact to contribute to this complex condition. Genetics plays a role, especially in Type 2 diabetes, where hereditary factors can affect susceptibility. However, genetics alone are not enough for the disease to develop; environmental factors also play a crucial part.


Lifestyle and environmental factors significantly contribute to the risk of diabetes. Unhealthy eating habits, characterized by high sugar, high fat, and low fiber consumption, are linked to an increased risk of diabetes. Additionally, sedentary lifestyles further decrease insulin sensitivity, making individuals more susceptible to diabetes. Even inadequate or disrupted sleep patterns can lead to insulin resistance, raising the risk of diabetes.


Furthermore, viral infections like Coxsackie and measles viruses have been suggested to potentially be connected to the onset of diabetes, particularly in children. On the other hand, Type 1 diabetes is primarily caused by an autoimmune response. In this type of diabetes, the immune system targets and impairs the function of insulin-producing pancreatic beta cells.


The management of diabetes is significantly influenced by dietary decisions. Consuming foods that are high in sugar, saturated fats, processed ingredients, sugary beverages, and candies can worsen the condition. Conversely, adopting a diet that is abundant in fiber, low in sugar, and low in saturated fats, which includes vegetables, fruits, whole grains, and fish, can be beneficial in the management of diabetes.


4. Diagnose and treatment

The Diabetes diagnosis is primarily through a combination of clinical presentation and specific blood tests. The following symptoms are often used to diagnose diabetes by the associated specialists in terms of the clinical presentation.


As per U.S. Pharmacist research, Polyuria, polydipsia, and polyphagia, along with fatigue, nausea, and impaired vision, are the most typical signs and symptoms of T1DM, all of which are brought on by hyperglycemia. Also, it is worth noting that these symptoms may appear suddenly (“Diabetes Mellitus Clinical Presentation,” 2022).


In the context of diagnosing diabetes, three primary sugar tests are commonly employed. According to the Mayo Clinic (2023), the first test is the random blood test, which involves measuring blood sugar levels at any given time, regardless of the individual's recent food intake. A blood sugar level of 200 milligrams per deciliter (mg/dL) or higher, equivalent to 11.1 millimoles per liter (mmol/L), is indicative of diabetes. The second test is the fasting blood sugar test, which requires the individual to abstain from eating overnight before a blood sample is taken. A fasting blood sugar level below 100 mg/dL (5.6 mmol/L) is considered normal, while a level between 100 and 125 mg/dL (5.6 to 6.9 mmol/L) is classified as prediabetes. If the fasting blood sugar level exceeds 126 mg/dL (7 mmol/L) in two separate tests, it confirms the presence of diabetes. Lastly, the glucose tolerance test involves fasting overnight, measuring the fasting blood sugar level, consuming a sugary liquid, and then monitoring blood sugar levels at regular intervals over the subsequent two hours. These three tests play a crucial role in diagnosing diabetes, enabling individuals to identify underlying health issues and promptly address them (Mayo Clinic, 2023).

As long as the diabetes are diagnosed, the associated specialists will employ different treatment to help patients control blood sugar levels, prevent complications, and improve their quality of life. The current treatment is shown as follows:

The management of diabetes encompasses various treatments, including the promotion of a healthy diet and physical activity. Adhering to a nutritious eating plan can effectively regulate blood sugar levels, while engaging in physical activity facilitates the movement of sugar into cells for energy, thereby reducing blood sugar levels. Despite their significance, these aspects are often overlooked by the majority of individuals (Mayo Clinic, 2023).

For individuals with type 1 and type 2 diabetes, medication-based treatments are typically employed. This may involve insulin therapy, which is essential for certain individuals and can be administered through injections or pumps. Additionally, oral medications such as metformin may be prescribed to aid in lowering blood sugar levels.

Furthermore, blood monitoring is utilized to track glucose levels and make necessary adjustments to treatment plans. In complex cases, a comprehensive management approach may be implemented to address challenging situations and manage comorbidities such as hypertension, high cholesterol, and cardiovascular disease.

Early detection and proactive treatment are crucial in mitigating the impact of diabetes. Ongoing research in areas such as continuous glucose monitoring and precision medicine holds promise for the development of more personalized and effective treatment strategies.


5. Conclusion

In conclusion, diabetes is a multifaceted and prevalent chronic illness that carries significant implications for global health. Diagnosis relies on clinical symptoms and various laboratory tests, while treatment involves lifestyle modifications, medications, and ongoing monitoring. The field of diabetes therapy is witnessing promising advancements in the form of continuous glucose monitoring and precision medicine, which hold the potential to improve patient outcomes.


The recognition and management of diabetes hold immense importance, given its escalating prevalence, associated complications, and substantial economic burden, thereby rendering it a critical public health concern. This study has explored innovative strategies for diabetes management, alongside discussing diagnostic criteria and existing treatment modalities.


References

Banday, M. Z., Sameer, A. S., & Nissar, S. (2019). Pathophysiology of diabetes: An overview. Avicenna Journal of Medicine, 10(4), 174. https://doi.org/10.4103/ajm.ajm_53_20

Catholic Health Initiatives. (n.d.). Diabetes. Chi-health. https://www.chihealth.com/en/services/primary-care/diabetes.html

Department of Health & Human Services. (2021, September 23). Diabetes - long-term effects. Better Health Channel. https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/diabetes-long-term-effects

Diabetes - Diagnosis and treatment - Mayo Clinic. (2023, September 15). https://www.mayoclinic.org/diseases-conditions/diabetes/diagnosis-treatment/drc-20371451

Diabetes - Symptoms and causes - Mayo Clinic. (2023, May 3). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444

Diabetes Mellitus Clinical Presentation. (2022, November 11). U.S. Pharmacist. https://www.uspharmacist.com/article/diabetes-mellitus-clinical-presentation

Ke, C., Narayan, K. V., Chan, J. C., Jha, P., & Shah, B. R. (2022). Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nature Reviews Endocrinology, 18(7), 413–432. https://doi.org/10.1038/s41574-022-00669-4

The facts, stats, and impacts of diabetes. (2023, April 4). Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/library/spotlights/diabetes-facts-stats.html

World Health Organization: WHO & World Health Organization: WHO. (2023). Diabetes. www.who.int. https://www.who.int/news-room/fact-sheets/detail/diabetes

Figures

bottom of page